Stellar Biotechnologies, Inc. Business Finance Contracts & Agreements
42 Contracts & Agreements
- Credit Agreements (1 contract)
- Equity Distribution Agreements (4)
- Exchange Agreements (1)
- Investor Rights Agreements (1)
- Note Agreements (1)
- Purchase Agreements (6)
- Share Agreements (1)
- Stock Agreements (1)
- Subscription Agreements (3)
- Underwriting Agreements (1)
- Warrant Agreements (22)
- Securities Purchase Agreement, dated October 30, 2024, between Edesa Biotech, Inc. and Pardeep Nijhawan Medicine Professional Corporation (Filed With SEC on October 31, 2024)
- Form of Warrant (Filed With SEC on October 31, 2024)
- Form of Common Share Purchase Warrant issued to H.C. Wainwright & Co., Inc. designees on June 7, 2019 (Filed With SEC on December 15, 2023)
- Credit Agreement, effective as of October 20, 2023, by and between the Company and Pardeep Nijhawan Medicine Professional Corporation (Filed With SEC on October 23, 2023)
- Equity Distribution Agreement, dated as of March 27, 2023, by and between Edesa Biotech, Inc. and Canaccord Genuity LLC (Filed With SEC on March 27, 2023)
- Form of U.S. Subscription Agreement (Filed With SEC on November 3, 2022)
- Form of Non-U.S. Subscription Agreement (Filed With SEC on November 3, 2022)
- Form of Class B Warrant (Filed With SEC on November 3, 2022)
- Form of Class A Warrant (Filed With SEC on November 3, 2022)
- Form of Securities Purchase Agreement, dated March 21, 2022, by and between the Company and the Purchaser (Filed With SEC on March 23, 2022)
- Form of Placement Agent Warrant (Filed With SEC on March 23, 2022)
- Form of Private Placement Warrant (Filed With SEC on March 23, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on March 23, 2022)
- First Amendment to Equity Distribution Agreement, dated as of March 4, 2022, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Filed With SEC on March 4, 2022)
- Equity Distribution Agreement, dated as of November 22, 2021, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Filed With SEC on November 22, 2021)
- Form of Underwriter Warrant (Filed With SEC on February 26, 2021)
- Underwriting Agreement (Filed With SEC on February 26, 2021)
- Equity Distribution Agreement, dated as of September 28, 2020, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Filed With SEC on September 28, 2020)
- Securities Purchase Agreement by and between Edesa Biotech, Inc. and NovImmune SA dated April 17, 2020 (Filed With SEC on April 23, 2020)
- Purchase Agreement by and between Edesa Biotech Research, Inc. and NovImmune SA dated April 17, 2020 (Filed With SEC on April 23, 2020)
- Form of Subscription Agreement between Edesa Biotech, Inc. and certain investors (Filed With SEC on January 6, 2020)
- Form of Warrant to be issued to Brookline Capital Markets, a division of Arcadia Securities, LLC (Filed With SEC on January 6, 2020)
- Form of Class B Purchase Warrant to be issued to investors (Filed With SEC on January 6, 2020)
- Form of Class A Purchase Warrant to be issued to investors (Filed With SEC on January 6, 2020)
- Share Exchange Agreement, dated as of March 7, 2019, by and between Stellar Biotechnologies Inc., Edesa Biotech Inc. and the Edesa Shareholders (Filed With SEC on March 8, 2019)
- Form of Placement Agent Warrant (Filed With SEC on May 30, 2018)
- Form of Series B Common Share Purchase Warrant (Filed With SEC on May 30, 2018)
- Form of Series A Common Share Purchase Warrant (Filed With SEC on May 30, 2018)
- Form of Warrant Exercise Agreement dated May 24, 2018 by and between Stellar Biotechnologies, Inc. and certain purchasers (Filed With SEC on May 30, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on May 15, 2018)
- Form of Placement Agent Warrant (Filed With SEC on May 15, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on May 15, 2018)
- Form of Warrant (Filed With SEC on May 15, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on May 8, 2018)
- Form of Placement Agent Warrant (Filed With SEC on May 8, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on May 8, 2018)
- Form of Warrant (Filed With SEC on May 8, 2018)
- COMMON SHARE PURCHASE WARRANT Stellarbiotechnologies, inc. (Filed With SEC on June 30, 2016)
- ***CONFIDENTIALTREATMENT REQUESTED*** Note: Confidential treatment requestedwith respect to certain portions hereof denoted with “***”. (Filed With SEC on May 17, 2016)
- Specimen Common Stock Certificate (Filed With SEC on August 28, 2015)
